Bliss GVS Pharma640.55
+0.00 (-3.73%)

Bliss GVS Pharma Share Price

640.55+0.00 (-3.73%)
+300.87% past 1 Year

Corporate filings & documents

Announcements

Please find enclosed herewith the disclosure of voting results of the Postal Ballot Notice dated September 28 2026 through the remote e-voting process along with the Scrutinizers Report/
5 days ago
Please find enclosed herewith the Disclosure of Voting Result of the Postal Ballot Notice dated September 28 2026 through the remote e-voting process alongwith the Scrutinizers Report
5 days ago
Please find enclosed herewith the Intimation under Regulation 30 of the SEBI Listing Regulations.
2 weeks ago
Please find enclosed herewith the Intimation under Regulation 30 of the SEBI Listing Regulations.
2 weeks ago
We wish to inform you that Asterisk Lifesciences Ltd UK a wholly owned subsidiary of Bliss GVS Pharma Limited has obtained marketing authorization from the Medicines & Healthcare products Regulatory Agency (MHRA) for Mesalazine 1g Suppositiories.
2 weeks ago
We wish to inform you that Asterisk Lifesciences Ltd UK a wholly owned subsidiary of Bliss GVS Pharma Limited has obtained marketing authorization from the Medicines & Healthcare products Regulatory Agency (MHRA) for Mesalazine 1g Suppositiories.
2 weeks ago
Please find enclosed herewith the Newspaper Publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2026.
2 weeks ago
Please find enclosed herewith the Newspaper Publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2026.
2 weeks ago
Please find enclosed herewith the outcome of Nomination and Remuneration Committee meeting held today i.e. on October 29 2026 the members has granted 2 95 000 stock options under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019
3 weeks ago
Please find enclosed herewith the outcome of Nomination and Remuneration Committee meeting held today i.e. on October 29 2026 the members has granted 2 95 000 stock options under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019
3 weeks ago
Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29 2026
3 weeks ago
Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29 2026
3 weeks ago
Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29 2026
3 weeks ago
Please find enclosed herewith the Outcome of Board Meeting which was held on today i.e. October 29 2026
3 weeks ago
Please find attached the unaudited standalone and consolidated financial results for the quarter and half year ended September 30 2026.
3 weeks ago
Please find attached the unaudited standalone and consolidated financial results for the quarter and half year ended September 30 2026.
3 weeks ago
Please find enclosed herewith the Newspaper Publication regarding the Postal Ballot Notice dated October 01 2026.
3 weeks ago
Please find enclosed herewith the Newspaper Publication regarding the Postal Ballot Notice dated October 01 2026.
3 weeks ago
Please find enclosed herewith the Postal Ballot Notice dated October 01 2026 ("Notice") alongwith the Explanatory Statement for seeking approval of the members of the Company by way of remote e-voting to transact the Special Business as set out in the Notice.
3 weeks ago
Please find enclosed herewith the Postal Ballot Notice dated October 01 2026 ("Notice") alongwith the Explanatory Statement for seeking approval of the members of the Company by way of remote e-voting to transact the Special Business as set out in the Notice.
3 weeks ago
Please find enclosed herewith the Postal Ballot Notice dated October 01 2026 ("Notice") alongwith the Explanatory Statement for seeking approval of the members of the Company by way of remote e-voting to transact the Special Business as set out in the Notice.
3 weeks ago
Please find enclosed herewith the Postal Ballot Notice dated October 01 2026 ("Notice") alongwith the Explanatory Statement for seeking approval of the members of the Company by way of remote e-voting to transact the Special Business as set out in the Notice.
3 weeks ago
Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Thursday October 29 2026 at the registered office of the Company to consider and approve inter alia the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2026.
1 month ago
Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Thursday October 29 2026 at the registered office of the Company to consider and approve inter alia the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2026.
1 month ago
Please find enclosed herewith the newspaper publication regarding the dispatch of Postal Ballot Notice.
1 month ago
Please find enclosed herewith the newspaper publication regarding the dispatch of Postal Ballot Notice.
1 month ago
Please find enclosed herewith Postal Ballot Notice dated September 28 2026 ("Notice") alongwith the Explanatory Statement for seeking approval of the members of the Company by way of remote e-voting to transact the Special businesses as set out in the Notice.
1 month ago
Please find enclosed herewith Postal Ballot Notice dated September 28 2026 ("Notice") alongwith the Explanatory Statement for seeking approval of the members of the Company by way of remote e-voting to transact the Special businesses as set out in the Notice.
1 month ago
We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. October 15 2026 has approved the allotment of 53 500 equity shares of the face value of Re 1 /- to the eligible employees who have exercised their options under the Bliss GVS Pharma Limited - Employee Stock option Plan (Bliss GVS ESOP - 2019)
1 month ago
We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. October 15 2026 has approved the allotment of 53 500 equity shares of the face value of Re 1 /- to the eligible employees who have exercised their options under the Bliss GVS Pharma Limited - Employee Stock option Plan (Bliss GVS ESOP - 2019)
1 month ago
Please find enclosed herewith the disclosure under Regulation 31A (10) of the SEBI Regulations in relation to re-classification from the "promoter and promoter Group category" to the "public" category
1 month ago
Please find enclosed herewith the disclosure under Regulation 31A (10) of the SEBI Regulations in relation to re-classification from the "promoter and promoter Group category" to the "public" category
1 month ago
Please find enclosed herewith the newspaper advertisement published regarding the Extension of Special Window for Re-Lodgement of Transfer Requests of Physical Shares.
1 month ago
Please find enclosed herewith the newspaper advertisement published regarding the Extension of Special Window for Re-Lodgement of Transfer Requests of Physical Shares.
1 month ago
Please find enclosed herewith the certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ended September 30 2026.
1 month ago
Please find enclosed herewith the certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ended September 30 2026.
1 month ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
1 month ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
1 month ago
Please find enclosed herewith the outcome of the Board Meeting held today i.e. Thursday October 01 2026 through Video Conferencing or Other Audio Visual Means.
1 month ago
Please find enclosed herewith the outcome of the Board Meeting held today i.e. Thursday October 01 2026 through Video Conferencing or Other Audio Visual Means.
1 month ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Anupam Rasayan India Ltd
1 month ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Anupam Rasayan India Ltd
1 month ago
Please find enclosed herewith the Intimation for the Closure of the Trading Window w.e.f. Thursday October 01 2026.
1 month ago
Please find enclosed herewith the Intimation for the Closure of the Trading Window w.e.f. Thursday October 01 2026.
1 month ago
Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2026 inter alia to consider and approve Please find enclosed herewith the Intimation of the Board Meeting to be held on Thursday October 01 2026.
1 month ago
Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2026 inter alia to consider and approve Please find enclosed herewith the Intimation of the Board Meeting to be held on Thursday October 01 2026.
1 month ago
Please find enclosed herewith the Outcome of the 2nd Board Meeting held on September 28 2026 at shorter Notice regarding re-classification from the "Promoter and Promoter Group" category to the "public" category.
1 month ago
Please find enclosed herewith the Outcome of the 2nd Board Meeting held on September 28 2026 at shorter Notice regarding re-classification from the "Promoter and Promoter Group" category to the "public" category.
1 month ago
Please find enclosed herewith the Outcome of the 1st Board Meeting held on September 28 2026 at shorter Notice pursuant to the consummation of the transaction contemplated in the share purchase agreement dated May 23 2026.
1 month ago
Please find enclosed herewith the Outcome of the 1st Board Meeting held on September 28 2026 at shorter Notice pursuant to the consummation of the transaction contemplated in the share purchase agreement dated May 23 2026.
1 month ago

Concalls & investor presentations

Empty box

No presentations found

Bliss GVS Pharma Ltd Share Price Today

The Bliss GVS Pharma Ltd share price today is ₹680.4. During the trading session, the Bliss GVS Pharma Ltd share price opened at ₹681 and recorded an intraday high of ₹700 and a low of ₹670. Last closing price was ₹694.45. Over the past 52 weeks, the Bliss GVS Pharma Ltd share price has ranged between ₹118 and ₹739.9. The current Bliss GVS Pharma Ltd stock price reflects real-time market activity based on executed trades on the exchange.